Search

everythinglearnresearchcommunity

for

Search:↓

Juvéderm Ultra Plus is safe and effective for treating severe nasolabial folds in Chinese subjects.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Different treatments for alopecia areata have unpredictable results and varying success rates.

Treatments for acute leukaemia lead to high remission rates, but relapses occur, requiring ongoing advancements in care.

Minoxidil promotes hair regrowth, but more research needed for effectiveness and response factors.

JAK inhibitors are effective for treating alopecia areata, with most patients seeing hair growth after treatment.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Laser treatment can effectively reduce unwanted hair growth, particularly for people with fair skin and dark hair.

Topical sensitizers have mixed success in treating alopecia areata.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

There is no standardized treatment for hidradenitis suppurativa, and individualized plans are needed.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

Minoxidil shows promise for alopecia areata, but more research is needed before it can be recommended as a primary treatment.

Ruby laser hair removal effectively reduces hair density and is preferred by most patients.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.